Latest News and Press Releases

MISSISSAUGA, Ontario, June 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is...

Tisento received U.S. FDA Fast Track designation for zagociguat for the treatment of MELAS.

CAMBRIDGE, Massachusetts, June 17, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to the discovery and development of therapeutic...

Mobilicom’s corporate presentation and investment thesis can be viewed here: LINK Palo Alto, California, June 17, 2025 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB), a provider of...

Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in combination with either pembrolizumab or cetuximab as a strategy to overcome tumor...

VANCOUVER, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce a non-brokered private placement (the “Offering”)...

Beneficient announced a settlement to all claims pending in the previously disclosed GWG Holdings bankruptcy case.

TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce that the Government of Nova Scotia has deemed the...

TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Fountain Asset Corp. (TSXV: FA) (“Fountain”) announced today its intention to effect a normal course issuer bid through the facilities of the TSX Venture...

– Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily achieved a 9.3 mmHg reduction in systolic blood pressure, and a 7.5 mmHg placebo-adjusted reduction (p=0.0024) at four weeks – –...